Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide is an experimental small molecule compound containing a benzamide moiety that is N-linked to a benzyl group and substituted with an alpha-D-galactopyranoside at the 3-position. It has not been approved for any therapeutic use and there are no known clinical trials or indications. The precise mechanism of action is not described in available sources. Its molecular formula is C20H23NO7 and it has been referenced under the synonym BAPG[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Benzyl-3-(alpha-D-galactopyranosyloxy)benzamide.